Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation (TAESR)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Hammersmith Hospitals NHS Trust.
Recruitment status was  Recruiting
Information provided by:
Hammersmith Hospitals NHS Trust Identifier:
First received: December 10, 2008
Last updated: June 27, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2012
  Estimated Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)